# Targeting Tumors from the Inside Out

Page: https://stenobird.com/podcast/the-bio-report-1092382/targeting-tumors-from-the-inside-out
Text version: https://stenobird.com/podcast/the-bio-report-1092382/targeting-tumors-from-the-inside-out.md
Podcast: [The Bio Report](https://stenobird.com/podcast/the-bio-report-1092382)
Published: 2026-01-14T08:00:00+00:00
Episode link: https://thebioreport.podbean.com/e/targeting-tumors-from-the-inside-out/
Audio file: https://mcdn.podbean.com/mf/web/pzyhgv7tqthya27s/BR-Marc_Iacobucci-1-14-26adils.mp3
Processing state: not_requested
JSON: https://stenobird.com/v1/public/podcasts/the-bio-report-1092382/episodes/targeting-tumors-from-the-inside-out
Duration seconds: 1600

## Resource

Systemic chemotherapy remains the foundation of cancer treatment, but its widespread toxicity too often cuts short potential therapeutic benefits. NanOlogy is developing a new approach—localized cancer therapy that keeps the drug where it’s needed most. We spoke to Marc Iacobucci, managing director of Nanology about the company’s precision particle engineering platform, how it transforms existing oncology drugs into microparticles optimized for intratumoral delivery; and how this enables sustained, high-concentration dosing inside tumors that destroys cancer cells, stimulates immune responses, and spares patients the debilitating effects of systemic chemotherapy.

## Actions

- request_transcript: `POST https://stenobird.com/v1/public/podcasts/the-bio-report-1092382/episodes/targeting-tumors-from-the-inside-out/transcription-requests` — Idempotently request low-priority transcript generation for this episode.
- read_markdown: `GET https://stenobird.com/podcast/the-bio-report-1092382/targeting-tumors-from-the-inside-out.md` — Read the agent-friendly Markdown representation of this episode resource.

A page view does not enqueue transcription. Agents should invoke `request_transcript` explicitly when they need this episode processed.

## Transcript

Full transcripts are not published on public pages unless there is a clear rights basis.